Sir, Dapsone syndrome is also called the "five-week dermatitis" because it occurs suddenly, 5-6 weeks after the administration of dapsone. This drug-induced hypersensitivity syndrome. also known as "sulfone syndrome", consists of exfoliative dermatitis and/or other skin rashes, generalized lymphadenopathy, hepatosplenomegaly, fever and hepatitis. Here, we report a case of dapsone hypersensitivity, where the rash affected the skin of whole body, yet spared the patches of leprosy and tinea versicolor.
A 26-year-old man, who was on multidrug treatment for borderline lepromatous leprosy for the past 1 month, presented with a history Anatopic response: Double sparing phenomenon in a patient with dapsone hypersensitivity syndrome of high-grade fever for 1 week, yellowish discoloration of the sclera, and a reddish pruritic rash. There were erythematous papules and confluent plaques on his face, neck, trunk and limbs with conspicuous sparing of the distal limbs in a glove and stocking pattern.There were some areas of icteric skin in between the confluent erythematous rash [ Figure 1 ]. Further examination revealed sparing of the scaly macules of tinea versicolor on the trunk [ Figure 2 ]. A biopsy specimen from an erythematous plaque on the thigh showed focal exocytosis with a superficial perivascular lymphocytic infiltrate [ Figure 3a ]. An incisional biopsy taken from the hypoesthetic patch on the leg revealed a flattened epidermis, separated from the dermal infiltrate by a Grenz zone of normal collagen, sparse lymphocytes and diffuse sheets of histiocytes in the mid and lower dermis [ Figure 3b ]. Acid-fast bacilli were abundantly seen (4+). Dapsone hypersensitivity syndrome was diagnosed. Dapsone was stopped and he was given oral prednisolone 40 mg daily for 1 week, tapered to 30 mg daily for the next 14 days. The dose was further tapered over another 3 weeks. He was subsequently restarted on leprosy treatment consisting of rifampin 600 mg monthly and clofazimine 50 mg daily with no recurrence of the eruption.
Dapsone syndrome is a drug-induced hypersensitivity reaction. Although the exact immune mechanisms are unclear, a combination of type I, type IV and perhaps type III Gel and Coomb ' s hypersensitivity reactions are implicated in its pathogenesis. The generation of toxic metabolites such as nitrosamines, and possibly other compounds, through the N-hydroxylation pathway of dapsone metabolis, coupled with genetic and environmental factors, is considered vital in the etiology. 1 Duration of onset of rash varies from 6 weeks to 6 months after initiating the treatment, to as short as 48 hrs. It is characterized by sudden onset of a papular or exfoliative rash, accompanied by fever, malaise and weakness, followed by jaundice and tenderness of the liver, lymphadenopathy and mononucleosis. In addition, hemolytic anemia, methemoglobinemia, eosinophilia, raised erythrocyte sedimentation rate, increased levels of serum bilirubin and raised liver enzymes may be seen.
The cutaneous manifestations of this syndrome show wide variations including erythroderma, papular erythematous eruptions, erythema multiforme, toxic epidermal necrolysis and Stevens-Johnson syndrome. Erythematous maculopapular rash and exfoliative dermatitis are present in the majority of cases.
The distinctive feature of our case was the sparing of leprosy patches and tinea versicolor lesions by the rash. The term "anatopic phenomenon" is used to describe this pattern, which includes the modulation of the inflammatory response of one dermatosis by another unrelated cutaneous infection at the same site. 2 The accepted theory is that nerve damage in leprosy may affect the microvasculature and the local immune response resulting in the nonexpression of the hypersensitivity reaction, resulting in the " islands of sparing in the deep red sea" picture. 3 The microvasculature of the skin is the final common pathway for the expression of erythema in various types of hypersensitivity reactions. Vasoactive amines that act on the microvasculature are also released by mast cells in type III hypersensitivity reactions (via complement activation) and type IV reactions (via interleukin-3). 4 Because the flare reaction is believed to be a neurogenic reflex, lack of neuropeptides will affect the expression of the drug reaction regardless of the type of hypersensitivity reaction involved. They have been found to enhance T-cell proliferation, immunoglobulin production, cytokine production/release and monocyte chemotaxis. Nerve damage in leprosy may not only affect the microvasculature, but may also affect the expression of a hypersensitivity reaction.
Two other cases have been reported under anatopic phenomena, including the sparing of leprosy patches by ampicillin hypersensitivity rash and dapsone hypersensitivity syndrome. 3, 4 Four cases were reported by Pakran et al., in which unrelated dermatoses (viral exanthem, acute generalized exanthematous pustulosis, polymorphous light eruption and irritant contact dermatitis) spared the sites affected with tinea versicolor. 2 They speculated that the presence of Malassezia spp. may be responsible for this, either by providing a physical barrier or by means of local immunomodulation. A similar case of dithranol-induced erythema sparing tinea versicolor affected skin was previously reported by Shenoy et al. 5 
